BMO Capital Starts Aquestive Therapeutics (AQST) at Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NVDA
6. AMAT
7. NRIX
8. SPY
9. OIG
10. BAC

Go back to BMO Capital Starts Aquestive Therapeutics (AQST) at Outperform

RBC Capital Starts Aquestive Therapeutics (AQST) at Outperform

August 20, 2018 8:07 AM EDT

RBC Capital analyst Randall Stanicky initiates coverage on Aquestive Therapeutics (NASDAQ: AQST) with an Outperform rating and a price target of $23.00.

Stanicky said with stable cash flows from Suboxone behind it and a broad pipeline ahead of it, AQST is well... More

JMP Securities Starts Aquestive Therapeutics (AQST) at Market Outperform

August 20, 2018 5:06 AM EDT

JMP Securities analyst Jason Butler initiates coverage on Aquestive Therapeutics (NASDAQ: AQST) with a Market Outperform rating and a price target of $29.00.

The analyst comments "The company's lead pipeline candidates address neurological diseases, where Aquestive is building commercial capabilities as it grows to... More